Interaction of blood components with cathelicidins and their modified versions.

[1]  C. Haynes,et al.  Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants , 2014, Science Translational Medicine.

[2]  S. Leong,et al.  Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt‐resistance, and biocompatibility , 2014, Biotechnology and bioengineering.

[3]  Liliane Schoofs,et al.  A comprehensive summary of LL-37, the factotum human cathelicidin peptide. , 2012, Cellular immunology.

[4]  D. Appelhans,et al.  Influence of fourth generation poly(propyleneimine) dendrimers on blood cells. , 2012, Journal of biomedical materials research. Part A.

[5]  Hamidreza Ghandehari,et al.  Cationic PAMAM dendrimers aggressively initiate blood clot formation. , 2012, ACS nano.

[6]  J. Horbańczuk,et al.  Cathelicidins: family of antimicrobial peptides. A review , 2012, Molecular Biology Reports.

[7]  B. Bechinger,et al.  The membrane interactions of antimicrobial peptides revealed by solid-state NMR spectroscopy. , 2012, Chemistry and physics of lipids.

[8]  T. Pufe,et al.  Antimicrobial Peptides: Multifunctional Drugs for Different Applications , 2012 .

[9]  Gisbert Schneider,et al.  Designing antimicrobial peptides: form follows function , 2012, Nature Reviews Drug Discovery.

[10]  H. Vogel,et al.  The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.

[11]  Yizhen Wang,et al.  Antimicrobial peptides derived from different animals: comparative studies of antimicrobial properties, cytotoxicity and mechanism of action , 2011 .

[12]  Ameena Meerasa,et al.  CH(50): a revisited hemolytic complement consumption assay for evaluation of nanoparticles and blood plasma protein interaction. , 2011, Current drug delivery.

[13]  Qian Ning,et al.  Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment. , 2010, Cancer letters.

[14]  R. Beuerman,et al.  Multivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural Diversities , 2010, International Journal of Peptide Research and Therapeutics.

[15]  R. Romero,et al.  Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers. , 2010, International journal of pharmaceutics.

[16]  Lihong Liu,et al.  Design, syntheses and evaluation of hemocompatible pegylated-antimicrobial polymers with well-controlled molecular structures. , 2010, Biomaterials.

[17]  K. Kuroda,et al.  Structural determinants of antimicrobial activity and biocompatibility in membrane-disrupting methacrylamide random copolymers. , 2009, Biomacromolecules.

[18]  P. Fallon,et al.  Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. , 2009, Blood.

[19]  J. Bang,et al.  Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity , 2009, Peptides.

[20]  Ralf Mikut,et al.  Interpretable Features for the Activity Prediction of Short Antimicrobial Peptides Using Fuzzy Logic , 2009, International Journal of Peptide Research and Therapeutics.

[21]  M. N. Melo,et al.  Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations , 2009, Nature Reviews Microbiology.

[22]  N. Kumar,et al.  A novel cationic‐peptide coating for the prevention of microbial colonization on contact lenses , 2008, Journal of applied microbiology.

[23]  Håvard Jenssen,et al.  Novel anti-infectives: is host defence the answer? , 2008, Current opinion in biotechnology.

[24]  Shih-Bin Lin,et al.  Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. , 2008, International journal of antimicrobial agents.

[25]  B. Applegate,et al.  Hemocompatibility of hydrophilic antimicrobial copolymers of alkylated 4-vinylpyridine. , 2007, Biomacromolecules.

[26]  A. Hovnanian,et al.  Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea , 2007, Nature Medicine.

[27]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[28]  Kai Hilpert,et al.  Sequence requirements and an optimization strategy for short antimicrobial peptides. , 2006, Chemistry & biology.

[29]  Kai Hilpert,et al.  High-throughput generation of small antibacterial peptides with improved activity , 2005, Nature Biotechnology.

[30]  Michael Cascio,et al.  De Novo Generation of Cationic Antimicrobial Peptides: Influence of Length and Tryptophan Substitution on Antimicrobial Activity , 2005, Antimicrobial Agents and Chemotherapy.

[31]  G. Tew,et al.  Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives. , 2004, Journal of the American Chemical Society.

[32]  M. Bryszewska,et al.  Preliminary evaluation of the behavior of fifth-generation thiophosphate dendrimer in biological systems. , 2004, Biomacromolecules.

[33]  A. Chu,et al.  Novel anticoagulant polyethylenimine: inhibition of thrombin-catalyzed fibrin formation. , 2003, Archives of biochemistry and biophysics.

[34]  H. Coenraad Hemker,et al.  Calibrated Automated Thrombin Generation Measurement in Clotting Plasma , 2003, Pathophysiology of Haemostasis and Thrombosis.

[35]  Yi-An Lu,et al.  Antimicrobial dendrimeric peptides. , 2002, European journal of biochemistry.

[36]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[37]  Robert E. W. Hancock,et al.  Improved Derivatives of Bactenecin, a Cyclic Dodecameric Antimicrobial Cationic Peptide , 1999, Antimicrobial Agents and Chemotherapy.

[38]  K. Berndt,et al.  Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37* , 1998, The Journal of Biological Chemistry.

[39]  R. Nagaraj,et al.  Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13‐residue peptide indolicidin , 1996, FEBS letters.

[40]  E. Krause,et al.  Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. , 1996, Biochemistry.

[41]  S. Haynie,et al.  Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin , 1995, Antimicrobial agents and chemotherapy.

[42]  D. Eisenberg,et al.  Analysis of membrane and surface protein sequences with the hydrophobic moment plot. , 1984, Journal of molecular biology.

[43]  S Chien,et al.  Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. , 1981, The American journal of medicine.

[44]  M. Scully,et al.  Inhibition Of Contact Activation By Platelet Factor 4 , 1980, Thrombosis and Haemostasis.

[45]  M. Seeberger,et al.  Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. , 2012, Transfusion medicine reviews.

[46]  Ralf Mikut,et al.  Computer-based analysis, visualization, and interpretation of antimicrobial peptide activities. , 2010, Methods in molecular biology.

[47]  R. Hancock,et al.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.

[48]  S. Bajaj,et al.  New Insights into How Blood Clots: Implications for the Use of APTT and PT as Coagulation Screening Tests and in Monitoring of Anticoagulant Therapy , 1999, Seminars in thrombosis and hemostasis.